Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Coronavirus pandemic likely to reduce volume of peripheral vascular procedures

The market share for medical devices meant to treat peripheral vascular diseases, including devices such as PTA balloon catheters, stents, atherectomy devices and vascular grafts are expected to suffer due to the coronavirus (COVID-19) pandemic, according to GlobalData, a leading data and analytics company.  The global atherectomy devices market, worth approximately $760m in 2019, may […]
Read more

Automakers rising to challenge of producing ventilators to combat COVID-19

Manufacturers across the automotive industry are working at breakneck speed, and with some success, to produce and assemble critical ventilators needed to combat the coronavirus (COVID-19), says GlobalData, a leading data and analytics company. Mike Vousden, Automotive Analyst at GlobalData, comments: “This truly is a historic moment in the automotive industry. Not since the two […]
Read more

Sub-Saharan Africa construction sector highly vulnerable to ancillary impact from coronavirus pandemic

Leading data and analytics company GlobalData has revised its construction output growth forecast for Sub-Saharan Africa (SSA) in 2020 to 3.6%, down from the previous projection of 6% (Q4 2019 update). The company’s latest report, ‘Global Construction Outlook to 2024 (COVID-19 Impact)’, states that the revision reflects the impact on the region’s economic activity and […]
Read more

Auto industry will look to China for rebound insights

As the Chinese Government announces it will maintain subsidies for electric vehicles and plug-in hybrids, an indication that it will support the industry in recovery; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “This is an important indicator that Beijing will support the automotive industry as it begins […]
Read more

GlobalData highlights intelligent process automation’s key role in DevOps’ success

Prompted by ongoing complexities around application modernization architectures, enterprise operations teams, business users and developers are discovering a new breed of highly automated platforms which drive iteration and innovation among microservices teams in support of a robust delivery pipeline, says GlobalData, a leading data and analytics company. Intelligent process automation (IPA) is the natural evolution […]
Read more

Rapid diagnostic tests to greatly increase testing capacity for diagnosing COVID-19

There is a current worldwide lack of testing capacity for the novel coronavirus (COVID-19) outbreak. The frontline response for diagnosing COVID-19 has been polymerase chain reaction (PCR) testing. Although PCR is the go-to test for diagnosing an infectious agent, the test protocol is complex and expensive as it is mainly suited to large, centralized diagnostic laboratories, and tests typically take four to six hours to complete, says GlobalData, a leading data and analytics company. The solution to a paucity of testing is rapid point-of-care (POC) tests, […]
Read more

US car market crash points to tough times ahead

Following the news that light vehicle sales in the US fell nearly 39% in March compared with last year; David Leggett, Automotive Editor at GlobalData, a leading data and analytics company, offers his view: “The sharp drop to US vehicle sales last month was widely expected as social distancing and lockdown measures took hold in […]
Read more

Global VC funding activity continues to remain subdued due to coronavirus outbreak

The number of venture capital (VC) funding announced deals declined by 22.5% during the week ended March, 29, 2020 compared to the previous week, according to GlobalData’s deals database. The subdued funding activity has been continuing in the last few weeks and could be attributed to the cautious approach of VC investors on the back of volatile market conditions since the outbreak of the coronavirus (COVID-19). Aurojyoti Bose, Analyst at GlobalData, comments: “Deal activity plunged in most […]
Read more

Deal activity in travel and tourism sector continues to remain subdued

The number of deals announced in the global travel and tourism sector decreased by 60% during the week ended March, 29, 2020 compared to the previous week, according to GlobalData’s deals database. The travel and tourism sector has been affected badly since the outbreak of the coronavirus (COVID-19) and the subdued activity could be attributed to volatile market conditions as a result of the outbreak. Aurojyoti Bose, Analyst at GlobalData, comments: “Deal activity plunged in most of the key markets such as the US, Japan, […]
Read more

Coronavirus outbreak to hamper oil and gas projects in emerging economies

One of the immediate effects of the coronavirus (COVID-19) pandemic on the oil and gas industry has been a global glut of crude oil supply amid already weak demand, resulting in a significant drop in oil prices. Ongoing projects across the industry will likely be impacted, which could potentially put further stress on the global economy, according to GlobalData, a leading data and analytics company. The company’s report: ‘Impact of COVID-19 on Emerging Economies’ analyses the effect […]
Read more

GlobalData sharply revises down forecast for construction output growth globally to just 0.5% in 2020

Prior to the coronavirus (COVID-19) outbreak, leading data and analytics company GlobalData had predicted that there would be an acceleration in the pace of growth in the global construction industry, but given the severe disruption in China and other leading economies worldwide following the outbreak, the forecast for growth in 2020 has now been revised down to 0.5% (from 3.1% previously). The current forecast assumes that the outbreak is contained across all major markets by the end of the second […]
Read more

Private medical insurance policies to suffer declines in the UK following COVID-19

Private medical insurance (PMI) in the UK is set to suffer declines as private hospitals reached a deal with the NHS to provide beds, ventilators, staff and space amid the coronavirus (COVID-19) pandemic, according to GlobalData, a leading data and analytics company. GlobalData’s UK Insurance Consumer Survey reveals that in 2019, 28.8% of respondents were concerned about the service provided by the NHS or waiting times for procedures. These were the main reasons why consumers were driven to purchase PMI, and this is a substantial increase on the 13.8% of respondents in 2018. Yasha Kuruvilla, Insurance Analyst at GlobalData, comments: “PMI […]
Read more

Online beer festival to leverage 83% of the UK consumers that drink alcohol

Following the coronavirus (COVID-19) outbreak, independent operators will see slowdowns in the on-trade sector. However, the UK-based craft beer club, Beer52, has created an innovative way to stay engaged with its consumers through hosting the world’s first online craft beer festival. Initiatives such as this will help drinks companies maintain their sales amid sector slowdowns, says GlobalData, a leading data and analytics company. Carmen Bryan, Consumer Analyst at GlobalData comments: “If the COVID-19 outbreak can teach us one thing, it’s that brands […]
Read more

Pipeline in vitro diagnostic products for coronavirus shifts towards point of care and rapid diagnostics

The coronavirus (COVID-19) pandemic has had a dramatic impact on the in vitro diagnostics (IVD) testing market resulting in reagent shortages, new product launches and a host of new pipeline products entering development, says GlobalData, a leading data and analytics company. The current test used to diagnose COVID-19 is an RT-PCR based assay. In recent months, the pandemic has led to overwhelming demands for RT-PCR reagents causing shortages in reagents required for key steps in the testing process, such as RNA extraction kits. Companies […]
Read more

75% of nanopharmaceuticals are in clinical development for oncology indications

Of the more than 230 nanopharmaceuticals in clinical development, 75% are for oncology indications, including many hard-to-treat cancers with few treatment options, according to GlobalData, a leading data and analytics company. Nanopharmaceuticals have many physical and biological advantages compared to conventional medicines, including enhanced efficacy and reduced toxicity, which are particularly important in treating cancer patients. One of the main areas of opportunity for nanomedicine to date has been oncology, with high levels of research and development (R&D) activity detected in the field.  GlobalData’s recent report, […]
Read more
,

Coronavirus is prompting suppliers of all shapes and sizes to adapt and support the healthcare system

Thus far, the novel coronavirus (COVID-19) pandemic has surpassed 860,000 confirmed cases globally and while the economic impact is weighing heavily across sectors, organizations are exploring creative ways of how to combat the outbreak. The responses are not only fighting COVID-19, supporting the general public and propping up the healthcare system, but they are also positioning suppliers favorably for the aftermath, says GlobalData, a leading data and analytics company. Organizations across various industries worldwide are pivoting in response to both the clinical and socio-economic effects of COVID-19 to help their local communities. For example, retailers are finding ways of dealing with high demand, […]
Read more
1 … 63 64 65 66 67 … 93